| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8966 |
| Human Intestinal Absorption | HIA+ | 0.9929 |
| Caco-2 Permeability | Caco2+ | 0.7753 |
| P-glycoprotein Substrate | Non-substrate | 0.7069 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9440 |
| Non-inhibitor | 0.9736 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9098 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9380 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7431 |
| CYP450 2D6 Substrate | Non-substrate | 0.9091 |
| CYP450 3A4 Substrate | Non-substrate | 0.6241 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7903 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8533 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9427 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8849 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9504 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8787 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9671 |
| Non-inhibitor | 0.9507 |
| AMES Toxicity | Non AMES toxic | 0.9484 |
| Carcinogens | Non-carcinogens | 0.8058 |
| Fish Toxicity | High FHMT | 0.9485 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9674 |
| Honey Bee Toxicity | High HBT | 0.7350 |
| Biodegradation | Not ready biodegradable | 0.8085 |
| Acute Oral Toxicity | III | 0.8573 |
| Carcinogenicity (Three-class) | Non-required | 0.4716 |